Cargando...
Clinical utility of vilazodone for the treatment of adults with major depressive disorder and theoretical implications for future clinical use
BACKGROUND: Vilazodone is the latest approved antidepressant available in the United States. Its dual mechanism of action combines the inhibition of serotonin transporters while simultaneously partially agonizing serotonin-1a (5-HT1A) receptors. This combined activity results in serotonin facilitati...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove Medical Press
2012
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3333788/ https://ncbi.nlm.nih.gov/pubmed/22536068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S20683 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|